Abstract
Alzheimer's disease (AD) is characterized by the accumulation of cerebral plaques composed of 40- and 42-amino acid β-amyloid (Aβ) peptides, and autosomal dominant forms of AD appear to cause disease by promoting brain Aβ accumulation. Recent studies indicate that postmenopausal estrogen replacement therapy may prevent or delay the onset of AD. Here we present evidence that physiological levels of 17β-estradiol reduce the generation of Aβ by neuroblastoma cells and by primary cultures of rat, mouse and human embryonic cerebrocortical neurons. These results suggest a mechanism by which estrogen replacement therapy can delay or prevent AD.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Glenner, G. & Wong, C.W. Alzheimer's disease: Initial report of the purification and characteristics of a novel cerebrovascular amyloid protein. Biochem. Bbphys. Res. Commun. 122, 885–890 (1984).
Masters, C.L. et al. Amyloid plaque core protein in Alzheimer's disease and Down's syndrome. Proc. Natl. Acad. Sci. U.S.A. 82, 4245–4249 (1985).
Haass, C., Hung, A.Y., Schlossmacher, M.G., Teplow, D.B. & Selkoe, D.J. β-amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268, 3021–3024 (1993).
Haass, C. & Selkoe, D.J. Cellular processing of β-amyloid precursor protein and genesis of the amyloid-β peptide. Cell 75, 1039 42 (1993).
Jaffe, A.B., Toran-Allerand, C.D., Greengard, P. & Gandy, S.E. Estrogen regulates metabolism of Alzheimer amyloid β precursor protein. J. Biol. Chem. 269, 13065–13068 (1994).
Wang, R., Sweeney, D., Gandy, S.E. & Sisodia, S.S. The profile of soluble amyloid β protein in cultured cell media. J. Biol. Chem. 271, 31894–31902 (1996).
Ausubel, F.M. et al. in Short Protocols in Molecular Biology, Second Edition, (John Wiley and Sons, New York, (1992).
Scheuner, D. et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 (1996).
Borchelt, D.R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1 -42/1 -40 ratio in vitro and in vivo. Neuron 17, 1005–1013 (1996).
Duff, K. et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710–713 (1996).
Citron, M. et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nature Med. 3, 67–72 (1997).
Iwatsubo, T. et al. Visualization of Aβ 42(43) and Aβ 40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ 42(43). Neuron 13, 45–53 (1994).
Perez-Tur, J. et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297–301 (1995).
Barelli, H. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides: their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic and cerebral amyloid angiopathy cases. Mol. Med. 3, 695–707 (1997).
Kim, K.S. et al. Detection and quantitation of amyloid β-peptide with monoclonal antibodies. Neurosci. Res. Commun. 7, 113–122 (1990).
Lu, B., Yokoyama, M., Dreyfus, C.F. & Black, I.B. Depolarizing stimuli regulate nerve growth factor gene expression in cultured hippocampal neurons. Proc. Natl. Acad. Sci. U.S.A. 88, 6289–6292 (1991).
Simons, M. et al. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16, 899–908 (1996).
Feingold, K.R., Galvin, L.A., Schambelan, M. & Sebastian, A. . in Cecil's Essentials of Medicine (eds. Andreoli, T. E., Carpenter, C. C. J., Plum, F. & Smith, L. H.) 478 (W. B. Saunders Co., Philadelphia, (1990).
Tang, M. et al. Effect of oestrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet 348, 429–432 (1996).
Luine, V. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp. Neurol. 89, 484–490 (1985).
Woolley, C.S. & McEwen, B.S. Roles of estradiol and progesterone in regulation of hippocampal dendritic spine density during the estrous cycle in the rat. J. Comp. Neurol. 336, 293–306 (1993).
Woolley, C.S., Weiland, N.G. McEwen, B.S. & Schwartzkroin, P. A. Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: correlation with dendritic spine density. J. Neurosci. 17, 1848–1859 (1997).
Toran-Allerand, C.D. The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant?. Dev. Neurosci. 18, 36–48 (1996).
Behl, C., Widman, M., Trapp, T. & Holsboer, F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473–482 (1995).
Larson, G.H. & Wise, P.M. Constitutive and regulated prolactin secretion: effects of estradiol. Biology of Reproduction. 50, 357–362 (1994).
Scammell, J.C., Burrage, T.C. & Dannies, P.S. Hormonal induction of secretory granules in a pituitary tumor cell line. Endocrinology 119, 1543–1548 (1986).
Xu, H. et al. Generation of Alzheimer β-amyloid protein in the trarns-Golgi network in the apparent absence of vesicle formation. Proc. Natl. Acad. Sci. U.S.A. 94, 3748–3752 (1997).
Xu, H., Greengard, P. & Gandy, S. Regulated formation of Golgi secretory vesicles containing Alzheimer β-amyloid precursor protein. J. Biol. Chem. 270, 23243–23255 (1995).
Xu, H., Sweeney, D., Greengard, P. & Gandy, S. Metabolism of Alzheimer β-amyloid precursor protein: regulation by protein kinase A in intact cells and in a cell-free system. Proc. Natl. Acad. Sci. U.S.A. 93, 4081–4083 (1996).
Vincent, B., Beaudet, A., Dauch, P., Vincent, J.P. & Checler, F. Distinct properties of neuronal and astrocytic endopeptidase 3. 4.24.16: a study on differentiation, sub-cellular distribution, and secretion processes. J. Neurosci. 16, 5049–5059 (1996).
Buxbaum, J.D. et al. Processing of Alzheimer beta/A4 amyloid precursor protein: Modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87, 6003–6006 (1990).
Thinakaran, G. et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17, 181–190 (1996).
Evans, R.M. The steroid and thyroid hormone receptor superfamily. Science 240, 889–895 (1988).
Desdouits, F., Buxbaum, J.D., Desdouits-Magnen, J., Nairn, A.C. & Greengard, P. Amyloid β peptide formation in cell-free preparations. J. Biol. Chem. 271, 24670–24674 (1996).
Weidemann, A. et al. Identification, biogenesis and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell 57, 115–126 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xu, H., Gouras, G., Greenfield, J. et al. Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides. Nat Med 4, 447–451 (1998). https://doi.org/10.1038/nm0498-447
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0498-447
This article is cited by
-
β2-Microglobulin coaggregates with Aβ and contributes to amyloid pathology and cognitive deficits in Alzheimer’s disease model mice
Nature Neuroscience (2023)
-
The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease
Molecular Neurobiology (2023)
-
Intestinal Flora Affect Alzheimer's Disease by Regulating Endogenous Hormones
Neurochemical Research (2022)
-
Sirtuins transduce STACs signals through steroid hormone receptors
Scientific Reports (2020)
-
Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia
Molecular Neurobiology (2020)